Navigation Links
Your Data: Use of pSilencer 1.0-U6 siRNA Expression Vector in the Analysis of Synaptotagmin Location and Function


Iezzi M, Kouri G, Fukuda M, Wollheim CB (2004) Synaptotagmin V and IX isoforms control Ca2+-dependent insulin exocytosis. J Cell Sci 117:3119-3127.

In a recently published paper in the Journal of Cell Science, Iezzi and colleagues used Ambions siRNA target finder and the pSilencer 1.0-U6 vector in an extensive study to investigate synaptotagmin location and function in rat pancreatic islets and in the clonal β cell line INS-1E. Synaptotagmins (Syts) are a family of proteins involved in Ca2+-triggered exocytosis (Chapman, 2002; Sdhof, 2002) of which vertebrates express at least 15 isoforms (Sdhof & Rizo, 1996; Rickman et al., 2004). Insulin exocytosis from pancreatic β cells is a Ca2+-dependent secretory process. However, previous studies have shown conflicting results as to which Syt isoform is present on the secretory granules in the native β cell. Iezzi and colleagues investigated Syt V and Syt IX as Syt V has been suggested to be one of the Ca2+ sensors for insulin exocytosis in the β cell (Gut et al., 2001). The involvement of Syt IX in insulin secretion was unclear at the time.

Western blotting and RT-PCR analysis revealed the presence of both Syt V and Syt IX in rat pancreatic islets and in INS-1E cells. The expression of Syt V was similar in the islets and in the cell lines, while Syt IX was expressed less in the rat pa ncreatic islets. Confocal microscopy showed that SytV and Syt IX co-localize with insulin-containing secretory granules which was confirmed by using a continuous sucrose density gradient. Interestingly, studies performed in primary pancreatic endocrine cells revealed that Syt V is present in glucagon-containing islet alpha-cells but is not expressed in β-cells whereas Syt IX is associated with insulin granules in β-cells.

To investigate the function of Syt V and Syt IX, the Syt isoforms were over-expressed or their levels reduced using RNA interference. Both proteins were produced at similar levels but the anti-Syt IX antibody recognised a smaller and a larger form of Syt IX. The two forms of Syt IX may be due to post-translational modification such as O-glycosylation and palmitoylation. Transient over-expression of Syt V and Syt IX did not alter exocytosis in INS-1E cells indicating that both proteins do not interfere with the stoichiometry of SNARE proteins whose over-expression has been shown to inhibit insulin exocytosis (Nagamatsu et al., 1999).

To investigate the hormone release, the pSilencer SytV and Syt IX siRNA expression plasmids were each transiently cotransfected into INS-1E cells with a plasmid encoding the human growth hormone hGH. hGH is targeted to insulin-containing granules and can be used to monitor exocytosis as an insulin substitute in a subpopulation of transfected cells (Iezzi et al., 2000). The pSilencer expression plasmids included GFP for identification of transfected cells. Silencing of SytV and Syt IX levels did not change basal secretion. However, glucose-induced insulin release was decreased suggesting that inhibition may be by impairment of the exocytotic process and that Syt V and Syt IX act as positive modulators of exocytosis. The addition of the phorbol ester PMA, which potentiates insulin exocytosis distal to the increase of cytosolic Ca2+ showed that both proteins are directly involved in the Ca2+-dependent stimulation of exocytosis. The association of Syt IX with insulin granules in β-cells suggests that Syt IX may be the Ca2+ sensor for insulin secretion in β-cells.


References

Chapman ER (2002) Synaptotagmin a Ca 2+ sensor that triggers exocytosis? Nat Rev Mol Cell Biol 3:498-508.

Gut A, Kiraly CE, Fukuda M, Mikoshiba K, Wollheim CB, Lang J (2001) Expression and localisation of synaptotagmin isoforms in endocrine beta-cells: their function in insulin exocytosis. J Cell Sci 114:1709-1716.

Iezzi M, Regazzi R, Wollheim, CB (2000) The Rab3-interacting molecule RIM is expressed in pancreatic beta-cells and is implicated in insulin exocytosis. FEBS Lett 26:66-70.

Nagamatsu S, Nakamichi Y, Yamamura C, Matsushima S, Watanabe T, Ozawa S, Furukawa H, Ishida H (1999) Decreased expression of t-SNARE, syntaxin 1, and SNAP-25 in pancreatic β -cells is involved in impaired insulin secretion from diabetic GK rat islets: restoration of decreased t- SNARE proteins improves impaired insulin secretion. Diabetes 48:2367-2373.

Rickman C, Craxton M, Osborne S, Davletov B (2004) Comparative analysis of tandem C2 domains from the mammalian synaptotagmin family. Biochem J (In press).

Sdhof TC (2002) Synaptotagmins: why so many? J Biol Chem 277:7629-7632.

Sdhof TC and Rizo J (1996) Synaptotagmins: C2-domain proteins that regulate membrane traffic. Neuron 17:379-388.


back to top


Ordering Information
Cat# Product Name Size 7208 pSilencer 1.0-U6 (linear) 20 rxns
'"/>

Source:


Page: All 1 2 3 4

Related biology technology :

1. Your Data: Detection of Oocyte-specific Gene Expression Using Ambions Cells-to-cDNA Kit
2. Your Data: RNAlater Stories
3. Your Data: Silencing Hepatitis C Virus Replication With In Vitro Transcribed siRNAs
4. Your Data: Silencing Neural Cell Adhesion Genes with In Vitro Transcribed siRNAs
5. Your Data: Silencing of a Pro-apoptotic Transcription Factor Using Synthetic siRNA
6. pSilencer 4.1-CMV: Versatile Vectors for Expression of siRNA, miRNA, and mRNA
7. Selecting siRNA Sequences to Incorporate into the pSilencer Vectors
8. Custom and library siRNA for efficient gene silencing
9. Custom and library siRNA for efficient gene silencing
10. Cancer siRNA Oligo Set Version 1.0
11. Library siRNA
Post Your Comments:
*Name:
*Comment:
*Email:


(Date:2/22/2017)... (PRWEB) , ... February 22, 2017 , ... ... announced the addition of Tom Perkins as European director. Operating from Pennside’s Zurich ... to Pennside. , Perkins joins Pennside after more than a decade with ...
(Date:2/21/2017)... 2017 Synthetic Biologics, Inc. (NYSE MKT: SYN), ... to protect and restore the health of patients, intends to report ... 2016 on Thursday, March 2, 2017, and to host a conference ... for the call is as follows: U.S. (toll free): ... ...
(Date:2/21/2017)... (PRWEB) , ... February 21, 2017 , ... ... VTX-1 Liquid Biopsy System , a fully automated benchtop system for collecting ... The VTX-1 is being launched at the Molecular Medicine Tri Conference (Tri-Con) Annual ...
(Date:2/21/2017)... (PRWEB) , ... February 21, 2017 , ... The medical ... for their use, in multiple areas of medicine, due to their differentiating characteristics. Stem ... and they have the ability to be induced to become tissue or organic-specific cells ...
Breaking Biology Technology:
(Date:2/8/2017)... (NASDAQ: AWRE ), a leading supplier of biometrics ... and year ended December 31, 2016. Revenue ... to $6.9 million in the same quarter last year. Operating ... compared to $2.6 million in the fourth quarter of 2015. ... million, or $0.02 per diluted share, which compares to $1.8 ...
(Date:2/8/2017)... YORK , Feb. 7, 2017 ... Driven largely by the confluence of organizations, desires ... distaste for knowledge-based systems (password and challenge questions), ... industrial, and government systems. The market is driven ... a demarcation between consumer and enterprise uses cases, ...
(Date:2/7/2017)... --  MedNet Solutions , an innovative SaaS-based eClinical technology ... is pleased to announce that the latest release of ... and award winning eClinical solution, is now available for ... a proven Software-as-a-Service (SaaS) clinical research technology platform that ... delivers an entire suite of eClinical tools to support ...
Breaking Biology News(10 mins):